Skip to main content
. Author manuscript; available in PMC: 2022 Mar 1.
Published in final edited form as: Leuk Lymphoma. 2020 Oct 28;62(3):606–613. doi: 10.1080/10428194.2020.1839651

Figure 2. Clinical staging breakdown.

Figure 2.

Proportionally there were more stage IV patients in the LAG-3 negative group and more low risk (stage I/II) patients in the LAG-3 positive group.